Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- C3334 (S)-KetoprofenSummary: COX-1 and COX-2 inhibitor
- C3453 Sulindac sulfoneSummary: COX-2 inhibitor and anti-inflammatory drug
- C3509 Chlorprothixene (hydrochloride)Summary: dopamine D2 receptor antagonist and GABAA receptor inhibitor
- C3098 L-Acetylcarnitine (hydrochloride)Summary: used in targeting cardiovascular pathologies and as an acetylcholine mimic.
- C3539 Losartan CarboxaldehydeSummary: inhibits endothelial cyclooxygenase (COX)-2 expression
- C3592 Spinosyn ASummary: insect nicotinic acetylcholinesterase receptors (nAChRs) agonist and potent insecticide
- C3597 CPHPCSummary: used with anti-SAP antibodies to eliminate amyloid deposits
- C3989 Chlorcyclizine (hydrochloride)Summary: histamine H1 receptor antagonist and inhibits HCV
- C3837 PimozideSummary: dopamine receptors inhibitor
- C3869 BQCATarget: AChRSummary: positive allosteric modulator of the M1 muscarinic acetylcholine receptor (mAChR)